Roche Toradol to be removed from pre-operative and operative settings at Owen Healthcare Hospitals.
ROCHE TORADOL REMOVAL FROM PRE-OP AND OPERATIVE SETTINGS as well as from labor and delivery rooms has been initiated by Owen Healthcare in response to "recent manufacturer labeling changes," the hospital pharmacy management company announced March 15. Owen directed pharmacists in its 270 hospitals to remove Toradol (ketorolac) from "those areas where its use is contraindicated."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth